Investor List:

Top BioTech Series B Investors in Raleigh-Durham / Southeast US (21)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top BioTech investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Andy Theronier, Partner at Greystone Group Inc.
Andy Theronier
Sweet spot: $1M
Range: $250K - $5.0M
Investors in New York (NY), Investors in Miami (FL), Investors in London, Investors in Hong Kong, Investors in Las Vegas (NV), Investors in Los Angeles (CA), Investors in San Diego (CA), Investors in Palo Alto (CA), Investors in Lakeland (FL), Investors in Tampa (FL), Investors in Orlando (FL)
Investors in Advertising (Pre-seed), Investors in Education (Pre-seed), Investors in MarketingTech (Pre-seed), Investors in Advertising (Pre-seed), Investors in MarketingTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Entertainment & Sports (Pre-seed), Investors in Entertainment & Sports (Pre-seed), Investors in MarketingTech (Pre-seed), Investors in Payments (Pre-seed), Investors in Education (Pre-seed), Investors in Real Estate/PropTech (Pre-seed), Investors in Media/Content (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health IT (Pre-seed), Investors in Media/Content (Pre-seed), Investors in MarketingTech (Pre-seed), Investors in Education (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Payments (Pre-seed), Investors in Advertising (Pre-seed), Investors in Real Estate/PropTech (Pre-seed), Investors in Payments (Pre-seed), Investors in FinTech (Pre-seed), Investors in Health IT (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Entertainment & Sports (Pre-seed), Investors in BioTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in Entertainment & Sports (Pre-seed), Investors in MarketingTech (Pre-seed), Investors in Advertising (Pre-seed), Investors in Real Estate/PropTech (Pre-seed), Investors in Education (Pre-seed), Investors in Health IT (Pre-seed), Investors in Media/Content (Pre-seed), Investors in Payments (Pre-seed), Investors in Entertainment & Sports (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in FinTech (Pre-seed), Investors in Advertising (Pre-seed), Investors in Real Estate/PropTech (Pre-seed), Investors in Media/Content (Pre-seed), Investors in Payments (Pre-seed), Investors in Real Estate/PropTech (Pre-seed), Investors in MarketingTech (Pre-seed), Investors in Health IT (Pre-seed), Investors in Entertainment & Sports (Pre-seed), Investors in FinTech (Pre-seed), Investors in Education (Pre-seed), Investors in Media/Content (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Advertising (Pre-seed), Investors in Health IT (Pre-seed), Investors in BioTech (Pre-seed), Investors in Education (Pre-seed), Investors in Payments (Pre-seed), Investors in Media/Content (Pre-seed), Investors in Real Estate/PropTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in FinTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in FinTech (Pre-seed), Investors in Health IT (Pre-seed), Investors in FinTech (Pre-seed), Investors in Advertising (Seed), Investors in Advertising (Seed), Investors in Education (Seed), Investors in Entertainment & Sports (Seed), Investors in MarketingTech (Seed), Investors in MarketingTech (Seed), Investors in Payments (Seed), Investors in Health & Hospital Services (Seed), Investors in Entertainment & Sports (Seed), Investors in BioTech (Seed), Investors in MarketingTech (Seed), Investors in Education (Seed), Investors in Media/Content (Seed), Investors in Payments (Seed), Investors in Real Estate/PropTech (Seed), Investors in MarketingTech (Seed), Investors in Health IT (Seed), Investors in Advertising (Seed), Investors in FinTech (Seed), Investors in Education (Seed), Investors in Real Estate/PropTech (Seed), Investors in Payments (Seed), Investors in Media/Content (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Entertainment & Sports (Seed), Investors in Health & Hospital Services (Seed), Investors in Advertising (Seed), Investors in Entertainment & Sports (Seed), Investors in Payments (Seed), Investors in Real Estate/PropTech (Seed), Investors in Media/Content (Seed), Investors in Health IT (Seed), Investors in MarketingTech (Seed), Investors in Education (Seed), Investors in Advertising (Seed), Investors in Entertainment & Sports (Seed), Investors in Real Estate/PropTech (Seed), Investors in BioTech (Seed), Investors in Payments (Seed), Investors in FinTech (Seed), Investors in Media/Content (Seed), Investors in Real Estate/PropTech (Seed), Investors in FinTech (Seed), Investors in MarketingTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Education (Seed), Investors in Advertising (Seed), Investors in Health IT (Seed), Investors in Entertainment & Sports (Seed), Investors in Media/Content (Seed), Investors in Payments (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Education (Seed), Investors in FinTech (Seed), Investors in Health IT (Seed), Investors in Media/Content (Seed), Investors in BioTech (Seed), Investors in Real Estate/PropTech (Seed), Investors in FinTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in FinTech (Seed), Investors in Advertising (Series A), Investors in Education (Series A), Investors in Advertising (Series A), Investors in Entertainment & Sports (Series A), Investors in MarketingTech (Series A), Investors in MarketingTech (Series A), Investors in Education (Series A), Investors in BioTech (Series A), Investors in Payments (Series A), Investors in Health & Hospital Services (Series A), Investors in Entertainment & Sports (Series A), Investors in Payments (Series A), Investors in FinTech (Series A), Investors in Media/Content (Series A), Investors in Health IT (Series A), Investors in MarketingTech (Series A), Investors in Real Estate/PropTech (Series A), Investors in Education (Series A), Investors in Real Estate/PropTech (Series A), Investors in MarketingTech (Series A), Investors in Advertising (Series A), Investors in BioTech (Series A), Investors in Media/Content (Series A), Investors in Entertainment & Sports (Series A), Investors in Payments (Series A), Investors in Health IT (Series A), Investors in Entertainment & Sports (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Advertising (Series A), Investors in Payments (Series A), Investors in Health & Hospital Services (Series A), Investors in Media/Content (Series A), Investors in Real Estate/PropTech (Series A), Investors in MarketingTech (Series A), Investors in Health IT (Series A), Investors in Advertising (Series A), Investors in Entertainment & Sports (Series A), Investors in Education (Series A), Investors in BioTech (Series A), Investors in Real Estate/PropTech (Series A), Investors in Payments (Series A), Investors in FinTech (Series A), Investors in Media/Content (Series A), Investors in MarketingTech (Series A), Investors in FinTech (Series A), Investors in Education (Series A), Investors in Real Estate/PropTech (Series A), Investors in Entertainment & Sports (Series A), Investors in Advertising (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Payments (Series A), Investors in Media/Content (Series A), Investors in Education (Series A), Investors in BioTech (Series A), Investors in FinTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Media/Content (Series A), Investors in BioTech (Series A), Investors in Real Estate/PropTech (Series A), Investors in FinTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in FinTech (Series A), Investors in Entertainment & Sports (Series B), Investors in Advertising (Series B), Investors in MarketingTech (Series B), Investors in MarketingTech (Series B), Investors in BioTech (Series B), Investors in Payments (Series B), Investors in Advertising (Series B), Investors in Education (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Real Estate/PropTech (Series B), Investors in Entertainment & Sports (Series B), Investors in FinTech (Series B), Investors in Media/Content (Series B), Investors in MarketingTech (Series B), Investors in Payments (Series B), Investors in MarketingTech (Series B), Investors in Education (Series B), Investors in Payments (Series B), Investors in Education (Series B), Investors in Advertising (Series B), Investors in Entertainment & Sports (Series B), Investors in Advertising (Series B), Investors in Media/Content (Series B), Investors in BioTech (Series B), Investors in Media/Content (Series B), Investors in Real Estate/PropTech (Series B), Investors in Entertainment & Sports (Series B), Investors in BioTech (Series B), Investors in Payments (Series B), Investors in Real Estate/PropTech (Series B), Investors in MarketingTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Entertainment & Sports (Series B), Investors in BioTech (Series B), Investors in Advertising (Series B), Investors in Real Estate/PropTech (Series B), Investors in Health IT (Series B), Investors in Education (Series B), Investors in MarketingTech (Series B), Investors in Media/Content (Series B), Investors in Payments (Series B), Investors in Entertainment & Sports (Series B), Investors in Real Estate/PropTech (Series B), Investors in FinTech (Series B), Investors in Advertising (Series B), Investors in Education (Series B), Investors in FinTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Payments (Series B), Investors in Media/Content (Series B), Investors in Education (Series B), Investors in BioTech (Series B), Investors in FinTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Media/Content (Series B), Investors in Health IT (Series B), Investors in BioTech (Series B), Investors in FinTech (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Real Estate/PropTech (Series B), Investors in FinTech (Series B), Investors in Raleigh-Durham / Southeast US (Other Lists), Investors in Los Angeles / Southern California (Other Lists), Investors in Diverse Investors (Other Lists), Investors in London (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in New York City (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Scott Rocklage, Partner at 5am Ventures
Scott Rocklage
5am Ventures·Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in San Francisco (CA), Investors in SF Bay Area (CA), Investors in Menlo Park (CA), Investors in Palm Beach Gardens (FL)
Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in BioTech (Series B), Investors in BioTech (Series B), Investors in Raleigh-Durham / Southeast US (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Inga Deakin, Principal at Molten Ventures
Inga Deakin
Molten Ventures·Principal
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Raleigh (NC), Investors in London
Investors in Medical Devices (Seed), Investors in Medical Devices (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Health IT (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed), Investors in Medical Devices (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Series A), Investors in Medical Devices (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series A), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series B), Investors in Medical Devices (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Raleigh-Durham / Southeast US (Other Lists), Investors in London (Other Lists)
Photo of Tom Masterson, Managing Director at Allele Capital Partners
Tom Masterson
Allele Capital Partners·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Photo of David Pierson, Managing Director at Syngenta Group Ventures
David Pierson
Syngenta Group Ventures·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Durham (NC)
Investors in Pharmaceuticals (Seed), Investors in AgTech (Seed), Investors in E-commerce (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in AgTech (Seed), Investors in E-commerce (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in E-commerce (Series A), Investors in AgTech (Series A), Investors in BioTech (Series A), Investors in AgTech (Series A), Investors in Pharmaceuticals (Series A), Investors in E-commerce (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B), Investors in AgTech (Series B), Investors in E-commerce (Series B), Investors in AgTech (Series B), Investors in Pharmaceuticals (Series B), Investors in E-commerce (Series B), Investors in BioTech (Series B), Investors in Raleigh-Durham / Southeast US (Other Lists)
Photo of Matt Hughes, Managing Director at Allele Capital Partners
Matt Hughes
Allele Capital Partners·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boca Raton (FL)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in FinTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in FinTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in FinTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in FinTech (Series A), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B), Investors in FinTech (Series B), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B), Investors in FinTech (Series B), Investors in Raleigh-Durham / Southeast US (Other Lists)
Photo of Ankit Bhargava, Managing Director at Allele Capital Partners
Ankit Bhargava
Allele Capital Partners·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Photo of Menachem Kranz, Managing Partner at Allele Capital Partners
Menachem Kranz
Allele Capital Partners·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boca Raton (FL)